Printer Friendly
The Free Library
19,585,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Biora Increases Its Focus On the Dental Market.


Business Editors

MALMO, Sweden--(BUSINESS WIRE)--Sept. 27, 2000

Biora AB (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
: BIORY, SSE (1) An earlier full-screen editor in OS/2.

(2) (Streaming SIMD Extensions) A series of additional instructions built into Pentium CPU chips for improved multimedia performance by performing mathematical operations on multiple sets of data at the
: BIOR) announces today that as a step in refining the biotech company, Biora AB is evaluating different options including selling off the BioEx part of its R&D portfolio. The company will concentrate on indications relating to the oral cavity oral cavity
n.
The part of the mouth behind the teeth and gums that is bounded above by the hard and soft palates and below by the tongue and the mucous membrane connecting it with the inner part of the mandible.
.

In a commentary, Biora's President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , Rickard Soderberg says:

- "As we presented in our six month report, we have already begun

financing portions of our R&D activities, that we call BioEx,

using external resources. The conditional loan of 15 million SEK SEK

In currencies, this is the abbreviation for the Swedish Krona.

Notes:
The currency market, also known as the Foreign Exchange market, is the largest financial market in the world, with a daily average volume of over US $1 trillion.


from Industrifonden for the project `Extra oral use of Emdogain

for wound healing' was a first step within the framework of our

new strategy. We are also evaluating other opportunities to

reduce the company's future development costs, for example

partnership with a suitable pharmaceutical company that can take

BioEx' research results to the market."

Biora develops manufactures and sells products for the treatment of periodontal disease Periodontal Disease Definition

Periodontal diseases are a group of diseases that affect the tissues that support and anchor the teeth. Left untreated, periodontal disease results in the destruction of the gums, alveolar bone (the part of the jaws where
 and for use in oral surgery. Using its proprietary technology and expertise, Biora aims to become a world leader in biology-based products for specialized dental therapy. Biora's American Depository Shares are listed on the Nasdaq National Market in the US and Biora's ordinary shares are listed on the "O-list" of the Stockholm Stock Exchange The Stockholm Stock Exchange (Swedish: Stockholmsbörsen) is a stock exchange located in Stockholm, Sweden. Founded in 1863 [1] it is the primary securities exchange of the Nordic Countries.  in Sweden.

This press release may contain certain forward- looking statements that relate to future events or future business and financial performance. Such statements can only be predictions and the actual events or results may differ from those discussed. The Company cautions that these statements are subject to important factors that could cause actual results to differ materially from those expressed or implied in such forward looking statements and are more fully discussed in periodic reports filed with Securities and Exchange Commission.

For further information, please contact:
- Rickard Soderberg, President and CEO of Biora, tel: +46 (0) 703 36 13 59

- Elisabeth Lavers, Biora US-investor relations, tel: +1 203 977 7797
COPYRIGHT 2000 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2000, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Sep 27, 2000
Words:328
Previous Article:EPMC Acquires Successful ''Golden Age'' Production Company Monogram Pictures, Inc.
Next Article:IntraNet Solutions Announces New Technologies for Developers.
Topics:



Related Articles
Biora's Principal Product Emdogain Approved By FDA For Minimally Invasive Surgical Treatment of Periodontitis.
Biora AB Issues Half Year Report.
Biora AB Malmo, Sweden Releases Q3 Report.
Year End Report 1999 for Biora AB.
Biora's Preclinical Studies Show That The Company's Main Product, Emdogain, Induces Cell Death In Human Cancer Cells.
Biora AB Reports For the First Quarter 2001.
Biora AB Report for the First Half Year 2001.
Get an annual fiscal examination. (President's Page).
A tribute & salute to ADAA 2002-2003. (President's Page).
Maximizing care through dental assistant expanded functions in a humanitarian mission. (The Army Goes Rolling Along ...).

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles